[Use of estrogen-progestins in secondary prevention].
Modena
M G
MG
Dipartimento di Medicina Interna, Università degli Studi di Modena.
Origliani
G
G
Rossi
R
R
D000368:Aged; D003327:Coronary Disease / Q000517:prevention & control*; D004311:Double-Blind Method; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage; D008875:Middle Aged; D045167:Progesterone Congeners / Q000008:administration & dosage; D012307:Risk Factors; D013997:Time Factors
D004966:Estrogens, Conjugated (USP); D045167:Progesterone Congeners; D017258:Medroxyprogesterone Acetate